Antibiotics-resistant Propionibacterium acne (P. acne) causes severe acne vulgaris, serious public health, and psychological threat. A new lytic bacteriophage (phage), ÏPaP11-13, infecting P. acne, was isolated from the sewage management center of Xinqiao Hospital. It can form transparent plaque with diameters of 1.0â~â5.0âmm on the double-layer agar plate, indicating a robust lytic ability against its host. Transmission electron microscopy (TEM) showed that ÏPaP11-13 belonged to the Siphoviridae family (head diameter 60â±â4.5ânm, tail length 170â±â6.4ânm, tail width 14â±â2.4ânm). The one-step growth curve showed the incubation period was 5âh, and the burst size was 26 PFU (plaque-forming unit)/cell. Moreover, it exhibited tolerance over a broad range of pH and temperature ranges but was utterly inactivated by ultraviolet (UV) irradiation for 1âh. The whole-genome sequencing results revealed ÏPaP11-13 had a linear dsDNA with 29,648âbp length. The G/C content was 54.08%. Non-coding RNA genes and virulence factors were not found. Forty five open reading frames (ORFs) were identified after online annotation. This study reports a novel P. acne phage ÏPaP11-13, which has a robust lytic ability, no virulence factors, and good stability. The characterization and genomic analysis of ÏPaP11-13 will develop our understanding of phage biology and diversity and provide a potential arsenal for controlling antibiotics-resistant P. acne-induced severe acne vulgaris.
Whole-genome sequencing, annotation, and biological characterization of a novel Siphoviridae phage against multi-drug resistant Propionibacterium acne.
阅读:3
作者:Liao Danxi, Zhang Jian, Liu Ruolan, Chen Kui, Liu Yuanyuan, Shao Yuming, Shi Xi, Zhang Yiming, Yang Zichen
| 期刊: | Frontiers in Microbiology | 影响因子: | 4.500 |
| 时间: | 2022 | 起止号: | 2023 Jan 4; 13:1065386 |
| doi: | 10.3389/fmicb.2022.1065386 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
